Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression

Journal of Psychiatric Research

Volumn 44, Issue 16, 2010, Pages 1205-1213

  Belzeaux, Raoul ^a,b   Formisano Tréziny, Christine ^c   Loundou, Anderson ^d   Boyer, Laurent ^e   Gabert, Jean ^c   Samuelian, Jean Claude ^f   Féron, François ^a   Naudin, Jean ^b   Ibrahim, El Chérif ^a  

^a Mediterranée University   (France)

^b HÔPITAL SAINTE MARGUERITE   (France)

^c University of the Mediterranean Aix Marseille II   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e TIMONE HOSPITAL   (France)

^f HÔPITAL DE LA CONCEPTION   (France)

Author keywords

5HTT; Candidate gene; Depression; PBMC; QPCR

Indexed keywords

AMISULPRIDE; BIOLOGICAL MARKER; CITALOPRAM; CLOMIPRAMINE; CYAMEMAZINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DULOXETINE; FLUOXETINE; HEAT SHOCK PROTEIN; HISTONE DEACETYLASE 5; HSPA2 PROTEIN; INTERLEUKIN 10; LITHIUM; MESSENGER RNA; MOCLOBEMIDE; NEU DIFFERENTIATION FACTOR; PAROXETINE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SORTILIN; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG; VALPROIC ACID; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR DEPRESSION; MALE; MENTAL PATIENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOLOGIC ASSESSMENT; PSYCHOPHARMACOTHERAPY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; AGED; ANTIDEPRESSIVE AGENTS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEUREGULIN-1; PSYCHIATRIC STATUS RATING SCALES; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRYPTOPHAN HYDROXYLASE;

EID: 78649703964     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.04.011     Document Type: Article

References (68)

1. American Psychiatric Association, AP Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Press, Whashington DC. 4th ed.
2. Aston C., Jiang L., Sokolov B.P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Molecular Psychiatry 2005, 10:309-322.
3. Begemann M., Sargin D., Rossner M.J., Bartels C., Theis F., Wichert S.P., et al. Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches. Molecular Medicine 2008, 14:546-552.
4. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society: Series B 1995, 57:289-300.
5. Bet P.M., Penninx B.W., Bochdanovits Z., Uitterlinden A.G., Beekman A.T., van Schoor N.M., et al. Glucocorticoid receptor gene polymorphisms and childhood adversity are associated with depression: new evidence for a gene-environment interaction. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2009, 150B:660-669.
6. Blendy J.A. The role of CREB in depression and antidepressant treatment. Biological Psychiatry 2006, 59:1144-1150.
7. Capuron L., Fornwalt F.B., Knight B.T., Harvey P.D., Ninan P.T., Miller A.H. Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?. Journal of Affective Disorders 2009, 119:181-185.
8. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
9. Choi K.H., Higgs B.W., Weis S., Song J., Llenos I.C., Dulay J.R., et al. Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects. BMC Psychiatry 2009, 9:57.
10. Choudary P.V., Molnar M., Evans S.J., Tomita H., Li J.Z., Vawter M.P., et al. Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15653-15658.
11. Conti B., Maier R., Barr A.M., Morale M.C., Lu X., Sanna P.P., et al. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Molecular Psychiatry 2007, 12:167-189.
12. de Jonge H.J., Fehrmann R.S., de Bont E.S., Hofstra R.M., Gerbens F., Kamps W.A., et al. Evidence based selection of housekeeping genes. PLoS ONE 2007, 2:e898.
13. Donnici L., Tiraboschi E., Tardito D., Musazzi L., Racagni G., Popoli M. Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells. BMC Neuroscience 2008, 9:61.
14. Eady J.J., Wortley G.M., Wormstone Y.M., Hughes J.C., Astley S.B., Foxall R.J., et al. Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiological Genomics 2005, 22:402-411.
15. Fujimoto M., Uchida S., Watanuki T., Wakabayashi Y., Otsuki K., Matsubara T., et al. Reduced expression of glyoxalase-1 mRNA in mood disorder patients. Neuroscience Letters 2008, 438:196-199.
16. Girgenti M.J., Nisenbaum L.K., Bymaster F., Terwilliger R., Duman R.S., Newton S.S. Antipsychotic-induced gene regulation in multiple brain regions. Journal of Neurochemistry 2010, 113:175-187.
17. Gladkevich A., Kauffman H.F., Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biological Psychiatry 2004, 28:559-576.
18. Glassman A.H., Miller G.E. Where there is depression, there is inflammation... sometimes!. Biological Psychiatry 2007, 62:280-281.
19. Guelfi J. L'évaluation standardisée en psychiatrie 1997, Edition Médicale Pierre Fabre, Lavaur.
20. Hobara T., Uchida S., Otsuki K., Matsubara T., Funato H., Matsuo K., et al. Altered gene expression of histone deacetylases in mood disorder patients. Journal of Psychiatric Research 2010, 44:263-270.
21. Iga J., Ueno S., Ohmori T. Molecular assessment of depression from mRNAs in the peripheral leukocytes. Annals of Medicine 2008, 40:336-342.
22. Iga J., Ueno S., Yamauchi K., Motoki I., Tayoshi S., Ohta K., et al. Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine. Neuroscience Letters 2005, 389:12-16.
23. Iga J., Ueno S., Yamauchi K., Numata S., Motoki I., Tayoshi S., et al. Gene expression and association analysis of LIM (PDLIM5) in major depression. Neuroscience Letters 2006, 400:203-207.
24. Iga J., Ueno S., Yamauchi K., Numata S., Kinouchi S., Tayoshi-Shibuya S., et al. Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression. Prog Neuropsychopharmacol Biological Psychiatry 2007, 31:628-632.
25. Iga J., Ueno S., Yamauchi K., Numata S., Tayoshi-Shibuya S., Kinouchi S., et al. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2007, 31:658-663.
26. Ikeda M., Tomita Y., Mouri A., Koga M., Okochi T., Yoshimura R., et al. Identification of novel candidate genes for treatment response to risperidone and susceptibility for schizophrenia: integrated analysis among pharmacogenomics, mouse expression, and genetic case-control association approaches. Biological Psychiatry 2010, 67:263-269.
27. Iwamoto K., Kakiuchi C., Bundo M., Ikeda K., Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Molecular Psychiatry 2004, 9:406-416.
28. Kalman J., Palotas A., Juhasz A., Rimanoczy A., Hugyecz M., Kovacs Z., et al. Impact of venlafaxine on gene expression profile in lymphocytes of the elderly with major depression-evolution of antidepressants and the role of the " neuro-immune" system. Neurochemical Research 2005, 30:1429-1438.
29. Kang H.J., Adams D.H., Simen A., Simen B.B., Rajkowska G., Stockmeier C.A., et al. Gene expression profiling in postmortem prefrontal cortex of major depressive disorder. Journal of Neuroscience 2007, 27:13329-13340.
30. Kendler K.S., Gardner C.O., Prescott C.A. Toward a comprehensive developmental model for major depression in men. American Journal of Psychiatry 2006, 163:115-124.
31. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Archives of General Psychiatry 2005, 62:529-535.
32. Kessing L.V. Epidemiology of subtypes of depression. Acta Psychiatrica Scandinavica 2007, 85-89. (Suppl.).
33. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Journal of the American Medical Association 2003, 289:3095-3105.
34. Klempan T.A., Sequeira A., Canetti L., Lalovic A., Ernst C., ffrench-Mullen J., et al. Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Molecular Psychiatry 2009, 14:175-189.
35. Le-Niculescu H., McFarland M.J., Mamidipalli S., Ogden C.A., Kuczenski R., Kurian S.M., et al. Convergent functional genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers. Neuroscience & Biobehavioral Reviews 2007, 31:897-903.
36. Le-Niculescu H., McFarland M.J., Ogden C.A., Balaraman Y., Patel S., Tan J., et al. Phenomic, convergent functional genomic, and biomarker studies in a stress-reactive genetic animal model of bipolar disorder and co-morbid alcoholism. American Journal of Medical Genetics part B Neuropsychiatric Genetics 2008, 147B:134-166.
37. Lee M.L., Whitmore G.A. Power and sample size for DNA microarray studies. Statistics in Medicine 2002, 21:3543-3570.
38. Liew C.C., Ma J., Tang H.C., Zheng R., Dempsey A.A. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. Journal of Laboratory and Clinical Medicine 2006, 147:126-132.
39. Matigian N., Windus L., Smith H., Filippich C., Pantelis C., McGrath J., et al. Expression profiling in monozygotic twins discordant for bipolar disorder reveals dysregulation of the WNT signalling pathway. Molecular Psychiatry 2007, 12:815-825.
40. Matuzany-Ruban A., Avissar S., Schreiber G. Dynamics of beta-arrestin1 protein and mRNA levels elevation by antidepressants in mononuclear leukocytes of patients with depression. Journal of Affective Disorders 2005, 88:307-312.
41. Mill J., Petronis A. Molecular studies of major depressive disorder: the epigenetic perspective. Molecular Psychiatry 2007, 12:799-814.
42. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry 2009, 65:732-741.
43. Molteni R., Calabrese F., Racagni G., Fumagalli F., Riva M.A. Antipsychotic drug actions on gene modulation and signaling mechanisms. Pharmacology & Therapeutics 2009, 124:74-85.
44. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
45. Ohayon M.M. Epidemiology of depression and its treatment in the general population. Journal of Psychiatric Research 2007, 41:207-213.
46. Otsuki K., Uchida S., Watanuki T., Wakabayashi Y., Fujimoto M., Matsubara T., et al. Altered expression of neurotrophic factors in patients with major depression. Journal of Psychiatric Research 2008, 42:1145-1153.
47. Rocca P., De Leo C., Eva C., Marchiaro L., Milani A.M., Musso R., et al. Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Prog Neuropsychopharmacol Biological Psychiatry 2002, 26:1155-1160.
48. Ryan M.M., Lockstone H.E., Huffaker S.J., Wayland M.T., Webster M.J., Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Molecular Psychiatry 2006, 11:965-978.
49. Schiepers O.J., Wichers M.C., Maes M. Cytokines and major depression. Prog Neuropsychopharmacol Biological Psychiatry 2005, 29:201-217.
50. Schlatter J., Ortuno F., Cervera-Enguix S. Lymphocyte subsets and lymphokine production in patients with melancholic versus nonmelancholic depression. Psychiatry Research 2004, 128:259-265.
51. Schmidt A.J., Hemmeter U.M., Krieg J.C., Vedder H., Heiser P. Impact of haloperidol and quetiapine on the expression of genes encoding antioxidant enzymes in human neuroblastoma SH-SY5Y cells. Journal of Psychiatric Research 2009, 43:818-823.
52. Segman R.H., Shefi N., Goltser-Dubner T., Friedman N., Kaminski N., Shalev A.Y. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Molecular Psychiatry 2005, 10:500-513. 425.
53. Sequeira A., Gwadry F.G., Ffrench-Mullen J.M., Canetti L., Gingras Y., Casero R.A., et al. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Archives of General Psychiatry 2006, 63:35-48.
54. Sequeira A., Klempan T., Canetti L., ffrench-Mullen J., Benkelfat C., Rouleau G.A., et al. Patterns of gene expression in the limbic system of suicides with and without major depression. Molecular Psychiatry 2007, 12:640-655.
55. Shao L., Vawter M.P. Shared gene expression alterations in schizophrenia and bipolar disorder. Biological Psychiatry 2008, 64:89-97.
56. Smith N.L., Hindorff L.A., Heckbert S.R., Lemaitre R.N., Marciante K.D., Rice K., et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. Journal of the American Medical Association 2007, 297:489-498.
57. Spitzer R.L., Williams J.B.W., Gibbon M. Structured clinical interview for DSM-III-R - patient edition/non-patient edition (SCID-P)/(SCID-NP) 1990, American Psychiatric Press Inc., Washington D.C.
58. Su T.P., Zhang L., Chung M.Y., Chen Y.S., Bi Y.M., Chou Y.H., et al. Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. Journal of Psychiatric Research 2009, 43:1078-1085.
59. Sullivan P.F., Fan C., Perou C.M. Evaluating the comparability of gene expression in blood and brain. American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2006, 141:261-268.
60. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: review and meta-analysis. American Journal of Psychiatry 2000, 157:1552-1562.
61. Surget A., Wang Y., Leman S., Ibarguen-Vargas Y., Edgar N., Griebel G., et al. Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversal. Neuropsychopharmacology 2009, 34:1363-1380.
62. Szegedi A., Jansen W.T., van Willigenburg A.P., van der Meulen E., Stassen H.H., Thase M.E. Early improvement in the first 2 weeks as a predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients. Journal of Clinical Psychiatry 2009, 70:344-353.
63. Tochigi M., Iwamoto K., Bundo M., Sasaki T., Kato N., Kato T. Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains. Neuroscience Research 2008, 60:184-191.
64. Tomita H., Vawter M.P., Walsh D.M., Evans S.J., Choudary P.V., Li J., et al. Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biological Psychiatry 2004, 55:346-352.
65. Tsao C.W., Lin Y.S., Chen C.C., Bai C.H., Wu S.R. Cytokines and serotonin transporter in patients with major depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2006, 30:899-905.
66. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 2002, 3. RESEARCH0034.
67. Wakabayashi Y., Uchida S., Funato H., Matsubara T., Watanuki T., Otsuki K., et al. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32:1199-1205.
68. Watanuki T., Funato H., Uchida S., Matsubara T., Kobayashi A., Wakabayashi Y., et al. Increased expression of splicing factor SRp20 mRNA in bipolar disorder patients. Journal of Affective Disorders 2008, 110:62-69.